4-HO-αMT
| Clinical data | |
|---|---|
| Other names | 4-HO-αMT; 4-HO-AMT; MP-14 |
| Routes of administration | Oral |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H14N2O |
| Molar mass | 190.246 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 125–126 °C (257–259 °F) |
| |
| |
| (verify) | |
4-Hydroxy-α-methyltryptamine (4-HO-αMT; developmental code name MP-14) is a psychedelic drug of the tryptamine and α-alkyltryptamine families. It is a close structural analogue of α-methyltryptamine (αMT) and produces similar effects to it, but with exacerbated side effects similarly to 5-MeO-αMT.